PSIL Price Forecast & ETF Analysis. Dividend · Expense Ratio · Holdings · NAV · RSI · MACD | US Stocks Today
AI-drawn chart patterns are for reference only.
Full metrics table
| Category | Global or ExUS Equities - Industry Sector | Expense | 1% | Return% 1Y | 24.26% | Total Holdings | 29 | Perf Week | 2.41% | Volume | 21,884 |
| Asset Type | Equities (Stocks) | AUM | $44M | Return% 3Y | 16.38% | NAV | $20.25 | Perf Month | -5.98% | Avg Volume | 0.03M |
| ETF Type | Global Equities | Dividend TTM | $1.68 (8.43%) | Return% 5Y | -24.55% | 52W High | -26.05% | Perf Quarter | -21.43% | Rel Volume | 0.69 |
| Active/Passive | Active | Div Gr. 3/5Y | 51.35% - | Return% 10Y | - | 52W Low | 27.79% | Perf Half Y | 0.25% | Prev Close | $20.23 |
| IPO | 2021/9/16 | Flows% 1M | 0% | Return% SI | -24.47% | RSI (14) | 43.98 | Perf YTD | 16.37% | Price | $19.98 |
| Beta | 0.99 | Flows% 3M | 6.11% | Flows% YTD | 120.27% | Flows% 1Y | 133.77% | Perf Year | 9.65% | Volatility(W/M) | 4.21% 3.63% |
| SMA20 | -1.72% | SMA50 | -10.02% | SMA200 | -3.97% | ATR | 0.77 | ||||
AdvisorShares Psychedelics ETF seeks long-term capital appreciation. The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from or devote 50% of their assets to psychedelic drugs and derivatives that have economic characteristics similar to such securities. The fund primarily invests in publicly listed life sciences companies focused on psychedelic medicines as well as other companies with activities in the psychedelics business. The fund is non-diversified.
The top 10 make up 69% of the fund
Concentrated in a few names. When they swing, the ETF swings with them.
DFTX DEFINIUM THERAPEUTICS INC 12.85% 2 
CMPS COMPASS PATHWAYS PLC 11.45% 3 
ATAI ATAIBECKLEY INC 10.47% 4 
RLMD RELMADA THERAPEUTICS INC 6.84% 5 
NRXP NRX PHARMACEUTICALS INC 6.07% 6 
NBIX NEUROCRINE BIOSCIENCES INC 4.38% 7 
HELP CYBIN INC 4.35% 8 
GHRS GH RESEARCH PLC 4.31% 9 
ALKS ALKERMES PLC 4.30% 10 
ANRO ALTO NEUROSCIENCE INC 4.20% Largest sectors first.
Over the past 1 year, roughly in the middle
26% below its 1-year high.
Traded less than usual. That is 69% of its average volume.
Holding long would have lost money
Bought 5 years ago, your return today would be -77.9%. The S&P 500 did +62% over the same period.
Tap to view numbers
The price swings wildly
At its worst (September 2021) it fell 93% and has not fully recovered yet.
Tap to view numbers
Dividends are paid consistently
Pays 8.43% annually in dividends.
Tap to view numbers
Money keeps flowing in
Over the past year, new money equal to 133.8% of assets came in.
Tap to view numbers
CURE Direxion Daily Healthcare Bull 3X ETF 211M 
RXL ProShares Ultra Health Care 2X Shares 117M 
XLVI State Street Health Care Select Sector SPDR Premium Income ETF 40M 
TBXU Direxion Daily Biotech Top 5 Bull 2X ETF 4M 
RXD-1× ProShares UltraShort Health Care -2x Shares 3M 
DRAM Roundhill Memory ETF 0.65% 
SECT Main Sector Rotation ETF 0.69% 
AVRE Avantis Real E state ETF 0.17% 
VOLT Tema Electrification ETF 0.75% 
CANC Tema Oncology ETF 0.75% 
HAUZ Xtrackers International Real Estate ETF 0.1% 
VNQI Vanguard Global ex-U.S. Real Estate ETF 0.12% 
PBPH Portfolio Building Block World Pharma and Biotech Index ETF 0.13% 
FAQ
How many holdings does PSIL have?
PSIL holds a total of 29 securities, with an AUM of approximately $44M.
Does PSIL pay dividends (distributions)?
PSIL's distribution yield is approximately 8.43%.
What is the 52-week high and low for PSIL?
PSIL has recorded a 52-week high of $27.02 and a low of $15.63.
